Anti-SIRPalpha Antibody for Tumor Treatment
Summary
USPTO published patent application US20260098102A1 by National University Corporation Kobe University on April 9, 2026. The application discloses an anti-SIRPα monoclonal antibody that binds human SIRPα to inhibit the SIRPα/CD47 interaction for use as an anti-tumor agent. The invention is classified under C07K 16/28 and related peptide technology categories.
What changed
USPTO published patent application US20260098102A1 for National University Corporation Kobe University on April 9, 2026. The application discloses an anti-SIRPα antibody composition for tumor treatment, where the antibody specifically binds human SIRPα to inhibit SIRPα/CD47 checkpoint interaction.
Organizations engaged in immunooncology research or developing SIRPα/CD47-targeted therapeutics should review the patent claims for potential infringement concerns and assess licensing requirements. The assignee, filing date, and scope of claims provide relevant competitive intelligence for entities in the antibody therapeutics space.
What to do next
- Review patent claims for infringement analysis
- Conduct freedom-to-operate assessment
- Monitor for related patent filings
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ANTI-SIRPalpha ANTIBODY
Application US20260098102A1 Kind: A1 Apr 09, 2026
Assignee
NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY
Inventors
Takashi MATOZAKI, Mayumi SUE, Kensuke NAKAMURA, Chigusa YOSHIMURA
Abstract
An anti-SIRPα antibody that can be used as a tumor agent and an anti-tumor agent comprising the antibody as an active ingredient. An antibody that binds specifically to human SIRPα to inhibit binding of human SIRPα to CD47.
CPC Classifications
C07K 16/2896 A61K 2039/505 A61P 35/00 C07K 16/2863 C07K 16/2887 C07K 16/32 C07K 2317/21 C07K 2317/565 C07K 2317/72 C07K 2317/732 C07K 2317/76
Filing Date
2025-10-30
Application No.
19374973
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.